Article
Lysophosphatidic acid (LPA)-antibody (504B3) validation by free-solution assay and interferometry identifies off-target binding
2020-10-05
Abstract excerpt
Antibody specificity and sensitivity is required in basic and clinical research for ensuring scientific rigor and reproducibility, while off-target cross-reactivity could generate erroneous conclusions. Lysophosphatidic acid (LPA) is a bioactive lipid being targeted clinically by antibody strategies. Here, we reexamined binding properties of a commercially available monoclonal antibody (504B3) reported as specific...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 72ae80a6-f2a3-595e-b37c-febf8e37fdab
- DOI
- 10.1101/2020.10.05.327122
